Acrivon Therapeutics, Inc. Common Stock (ACRV) is a publicly traded Healthcare sector company. As of July 22, 2026, ACRV trades at $1.76 with a market cap of $74.48M and a P/E ratio of -0.86. ACRV moved +1.15% today. Year to date, ACRV is -27.39%; over the trailing twelve months it is +25.00%. Its 52-week range spans $1.05 to $8.00. Analyst consensus is strong buy with an average price target of $10.50. Rallies surfaces ACRV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ACRV, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $1.76 |
| Market Cap | $74.48M |
| P/E Ratio | -0.86 |
| EPS | $-2.02 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.00 |
| 52-Week Low | $1.05 |
| Volume | 118.28K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-77.91M |
| Gross Margin | 0.00% |
5 analysts cover ACRV: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.50.